Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Perez-Martinez

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Expert Review of Cardiovascular Therapy|December 23, 2016
Drug therapy for ectopic fat: myth or reality?Niki Katsiki, Pablo Perez-Martinez
Clinical Endocrinology|March 1, 2013
It is time to define metabolically obese but normal-weight (MONW) individualsJose Lopez-Miranda, Pablo Perez-Martinez
Current Vascular Pharmacology|October 31, 2013
Editorial: nutritional therapy in metabolic syndromePablo Perez-Martinez, Jose Lopez-Miranda
Angiology|April 11, 2019
The Role of n-3 Fatty Acids in Cardiovascular Disease: Back to the FuturePablo Perez-Martinez, Niki Katsiki, Dimitri P Mikhailidis
Current Pharmaceutical Design|March 21, 2017
Homocysteine and Non-Cardiac Vascular DiseaseNiki Katsiki, Pablo Perez-Martinez, Dimitri P Mikhailidis
Frontiers in Cardiovascular Medicine|November 15, 2021
Could Statin Therapy Be Useful in Patients With Coronavirus Disease 2019 (COVID-19)?Jose D Torres-Peña, Niki Katsiki, Pablo Perez-Martinez
Biochimica Et Biophysica Acta|September 29, 2009
n-3 PUFA and lipotoxicityPablo Perez-Martinez, Francisco Perez-Jimenez, Jose Lopez-Miranda
Current Opinion in Cardiology|June 22, 2022
Diet and vascular riskFrancisco Gomez-Delgado, Juan Luis Romero-Cabrera, Pablo Perez-Martinez
BMC Proceedings|August 16, 2023
The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease - expert panel meeting reportLilian Grigorian-Shamagian, Antonio Coca, Joao Morais, et al.
Expert Review of Clinical Pharmacology|January 6, 2018
Dyslipidaemia in the elderly: to treat or not to treat?Niki Katsiki, Genovefa Kolovou, Pablo Perez-Martinez, et al.
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Expert Review of Cardiovascular Therapy|December 23, 2016
Drug therapy for ectopic fat: myth or reality?Niki Katsiki, Pablo Perez-Martinez
Clinical Endocrinology|March 1, 2013
It is time to define metabolically obese but normal-weight (MONW) individualsJose Lopez-Miranda, Pablo Perez-Martinez
Current Vascular Pharmacology|October 31, 2013
Editorial: nutritional therapy in metabolic syndromePablo Perez-Martinez, Jose Lopez-Miranda
Angiology|April 11, 2019
The Role of n-3 Fatty Acids in Cardiovascular Disease: Back to the FuturePablo Perez-Martinez, Niki Katsiki, Dimitri P Mikhailidis
Current Pharmaceutical Design|March 21, 2017
Homocysteine and Non-Cardiac Vascular DiseaseNiki Katsiki, Pablo Perez-Martinez, Dimitri P Mikhailidis
Frontiers in Cardiovascular Medicine|November 15, 2021
Could Statin Therapy Be Useful in Patients With Coronavirus Disease 2019 (COVID-19)?Jose D Torres-Peña, Niki Katsiki, Pablo Perez-Martinez
Biochimica Et Biophysica Acta|September 29, 2009
n-3 PUFA and lipotoxicityPablo Perez-Martinez, Francisco Perez-Jimenez, Jose Lopez-Miranda
Current Opinion in Cardiology|June 22, 2022
Diet and vascular riskFrancisco Gomez-Delgado, Juan Luis Romero-Cabrera, Pablo Perez-Martinez
BMC Proceedings|August 16, 2023
The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease - expert panel meeting reportLilian Grigorian-Shamagian, Antonio Coca, Joao Morais, et al.
Expert Review of Clinical Pharmacology|January 6, 2018
Dyslipidaemia in the elderly: to treat or not to treat?Niki Katsiki, Genovefa Kolovou, Pablo Perez-Martinez, et al.
Pageof 19